Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2011 · first_quarter · 1A
HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, State, Dept of (DOS)
Source: Senate LDA
HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes
To suspend temporarily the duty on certain non-toric shaped polarized materials of 80 mm or less in diameter.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes
To suspend temporarily the duty on certain non-toric shaped polarized materials of 80 mm or less in diameter.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap program 340B Drug Pricing program issues (currently unassigned), including program expansion
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care, including provisions regarding Medicaid rebates and patient savings in Medicare Part D coverage gap
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care, including provisions regarding Medicaid rebates and patient savings in Medicare Part D coverage gap
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare/Medicaid dual eligibles HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding patient savings in Medicare Part D coverage gap HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare Part D pharmaceutical pricing
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care, including provisions regarding Medicaid rebates and patient savings in Medicare Part D coverage gap
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care, including provisions regarding Medicaid rebates and patient savings in Medicare Part D coverage gap
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare/Medicaid dual eligibles HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding patient savings in Medicare Part D coverage gap HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare Part D pharmaceutical pricing
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap program 340B Drug Pricing program issues (currently unassigned), including program expansion
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap program 340B Drug Pricing program issues (currently unassigned), including program expansion
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Proposed revisions to 340B program HR 3590, S 1796, and related bills and amendments - Legislative proposals surrounding health care reform, including provisions regarding pharmaceutical pricing, insurance reform, and reimbursement issues
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Provisions within health care reform regarding drug rebates for Medicare/Medicaid Dual Eligibles HR 3590, S 1796, and related bills and amendments - Legislative proposals in health care reform aimed at patient savings during Part D coverage gap
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Care Reform S.301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Discuss Patient Assistance Programs Issues regarding disclosure of drug sample data Independent Drug Education and Outreach Act - Academic Detailing issues VA/DoD regarding TRICARE retail rebate legislation Veterans Health Care Budget Reform and Transparency Act Discussions regarding global access to medicines
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Provisions within health care reform regarding drug rebates for Medicare/Medicaid Dual Eligibles HR 3590, S 1796, and related bills and amendments - Legislative proposals in health care reform aimed at patient savings during Part D coverage gap
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Proposed revisions to 340B program HR 3590, S 1796, and related bills and amendments - Legislative proposals surrounding health care reform, including provisions regarding pharmaceutical pricing, insurance reform, and reimbursement issues
Safeguarding America's Pharmaceuticals Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions regarding protection of patient safety from the commercial importation of prescription medications Discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment - No specific legislation HR 5839-The Safeguarding America's Pharmaceuticals Act-US House Import Safety Discussion Draft legislation-US House/US Senate
Safeguarding America's Pharmaceuticals Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions regarding protection of patient safety from the commercial importation of prescription medications Discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment - No specific legislation HR 5839-The Safeguarding America's Pharmaceuticals Act-US House Import Safety Discussion Draft legislation-US House/US Senate
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1145-The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Discussions regarding intellectual property issues with Members and Staff-US House Discussions regarding authorized generics legislation-US House/US Senate Discussions regarding Patent Settlements (reverse payments) Legislation-US House/US Senate
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1145-The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Discussions regarding intellectual property issues with Members and Staff-US House Discussions regarding authorized generics legislation-US House/US Senate Discussions regarding Patent Settlements (reverse payments) Legislation-US House/US Senate
Physician Payments Sunshine Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Pulmonary and Cardiac Rehabilitation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Pulmonary and Cardiac Rehabilitation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Healthy Americans Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Healthy Americans Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Healthy Americans Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
American Samoa Possession Tax Credit Act of 2003
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
American Samoa Possession Tax Credit Act of 2003
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
American Samoa Possession Tax Credit Act of 2003
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Protecting Consumer Access to Generic Drugs Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Food and Drug Administration Amendments Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
Food and Drug Administration Amendments Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Stem Cell Research Enhancement Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
Food and Drug Import Safety Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1145/1908 The Patent Reform Act of 2007 - Potential implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries
340B Program Improvement and Integrity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
Children's Health Insurance Program Reauthorization Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Stem Cell Research Enhancement Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
To require cigarette products to be placed under or behind the counter in retail sales.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
2011 · first_quarter · Q1
HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · fourth_quarter · 4A
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · fourth_quarter · Q4
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · third_quarter · Q3
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap program 340B Drug Pricing program issues (currently unassigned), including program expansion
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · second_quarter · 2A
H.R. 3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care, including provisions regarding Medicaid rebates and patient savings in Medicare Part D coverage gap
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · second_quarter · Q2
H.R. 3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care, including provisions regarding Medicaid rebates and patient savings in Medicare Part D coverage gap
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · first_quarter · Q1
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare/Medicaid dual eligibles HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding patient savings in Medicare Part D coverage gap HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare Part D pharmaceutical pricing
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · fourth_quarter · Q4
HR 3590, S 1796, and related bills and amendments - Proposed revisions to 340B program HR 3590, S 1796, and related bills and amendments - Legislative proposals surrounding health care reform, including provisions regarding pharmaceutical pricing, insurance reform, and reimbursement issues
HR 3590, S 1796, and related bills and amendments - Provisions within health care reform regarding drug rebates for Medicare/Medicaid Dual Eligibles HR 3590, S 1796, and related bills and amendments - Legislative proposals in health care reform aimed at patient savings during Part D coverage gap
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · third_quarter · Q3
Proposals regarding changes to Medicaid rebate Proposals regarding Medicare Part D health care reform issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · first_quarter · 1A
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · second_quarter · Q2
Health Care Reform S.301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Discuss Patient Assistance Programs Issues regarding disclosure of drug sample data Independent Drug Education and Outreach Act - Academic Detailing issues VA/DoD regarding TRICARE retail rebate legislation Veterans Health Care Budget Reform and Transparency Act Discussions regarding global access to medicines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · first_quarter · Q1
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · third_quarter · 3A
Discussions regarding protection of patient safety from the commercial importation of prescription medications Discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment - No specific legislation HR 5839-The Safeguarding America's Pharmaceuticals Act-US House Import Safety Discussion Draft legislation-US House/US Senate
S.1145-The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Discussions regarding intellectual property issues with Members and Staff-US House Discussions regarding authorized generics legislation-US House/US Senate Discussions regarding Patent Settlements (reverse payments) Legislation-US House/US Senate
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · fourth_quarter · Q4
Medcaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act S.3118-The Preserving Access to Medicare Act Waxman proposal for Medicaid-type rebates for dual elibigles enrolled in Medicare Part D. No active legislation-US House Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D Anti-Preemption Medicare Part D-US House
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · third_quarter · Q3
S.1145-The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Discussions regarding intellectual property issues with Members and Staff-US House Discussions regarding authorized generics legislation-US House/US Senate Discussions regarding Patent Settlements (reverse payments) Legislation-US House/US Senate
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · second_quarter · Q2
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · first_quarter · 1A
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate General discussion and increasing awareness of patient assistance program offerings Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and MedicareAdvantage
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · first_quarter · Q1
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate General discussion and increasing awareness of patient assistance program offerings Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and MedicareAdvantage H.R. 3162 - Children's Health and Medicare Protection Act of 2007 - regarding Medicare Physician Reimbursement Package, Medicare and Medicaid Drug Reimbursement
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2007 · year_end · YY
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Proposed increase in Medicaid Drug Rebate drug base rebate increase Proposed changes to Medicaid price reporting and requirements from earlier legislation (DRA) Medicare Part D formulary protection for six specified classes
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2007 · mid_year · MM
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
Discussions regarding FDA Appropriations Discussions regarding e-Prescribing Discussions regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Regarding e-Prescribing Regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Discussions regarding FDA Appropriations Discussions regarding e-Prescribing Discussions regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
Discussions regarding protection of patient safety from the commercial importation of prescription medications Discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment - No specific legislation HR 5839-The Safeguarding America's Pharmaceuticals Act-US House Import Safety Discussion Draft legislation-US House/US Senate
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Renewal of Research and Development Tax Credit within context of proposed changes to Alternative Minimum Tax
S.1145/1908 The Patent Reform Act of 2007 - Potential implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries
Patient safety from the commercial importation of prescription medications Manufacturer outsourcing of active pharmaceutical ingredients to certain countries
Illegal compounding of commercially available pharmaceuticals by pharmacists
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE